Three more new members at CLIB!

We are very pleased to introduce our three new additions to the network!

Join us in welcoming:

Zentis GmbH & Co.KG

“For over 125 years, Zentis has been an indispensable source of inspiration for natural and enjoyable nutrition. Unparalleled expertise in refining natural raw materials such as fruits, vegetables and grains, outstanding innovative strength and a consistent quality policy have made Zentis one of Europe’s leading fruit processors and an indispensable partner for the processing industry and retailers. Zentis preparations refine dairy products, milk alternatives and baked goods. Zentis also produces fruity spreads and marzipan specialties.
Founded in 1893 in Aachen, the family-owned company is internationally positioned and has approximately 2,000 employees worldwide (1,100 in Aachen). In addition to 2 production sites in Germany, Zentis has plants in Poland, Hungary and the United States.”

and

ChiralVision B.V.

“ChiralVision produces immobilized enzymes and develops chemo-enzymatic processes for various markets including the environmental, cosmetic, fine chemical and pharmaceutical industry. Immobilization techniques are developed and used to produce immobilized enzymes in order to facilitate their separation, recycling and allow for continuous processes. Immobilization of enzymes makes processes more economically viable. Additionally the use of more extreme process conditions are possible for immobilized enzymes thereby increasing the technical feasibility of enzymatic processes.
ChiralVision also has a portfolio of unique enzymatically produced chiral compounds like unnatural amino acids.”

and

Biomatter Designs, UAB

“Biomatter is a synthetic biology company that creates new proteins for health and sustainable manufacturing. The company has developed the Intelligent Architecture™ platform that addresses limitations of current engineering approaches to unlock completely new horizons for digital protein design and development. Biomatter partners with leading companies from diverse industries to create new products and technologies based on unique enzymes that capture existing markets and enable blue-ocean opportunities. “